Upgrade to SI Premium - Free Trial

Aclaris Therapeutics (ACRS) Announces U.S. Patent for JAK Inhibitor to Treat Hair Loss

March 9, 2018 8:02 AM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News

Next Articles